Evidence map›Paper›PMID 37841093›Full record

ArticleAccess microbiology2023

Monitoring and tracking the spread of SARS-CoV-2 in Asturias, Spain.

Jose Maria Gonzalez-Alba, Susana Rojo-Alba, Zulema Perez-Martinez, Jose A Boga, Marta Elena Alvarez-Arguelles, Juan Gomez, Pablo Herrero, Isabel Costales, Luz Maria Alba, Gabriel Martin-Rodriguez and 12 more

Abstract read
In one paragraph

Article in Access microbiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Association ofLife (Basel, Switzerland) · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Jose Maria Gonzalez-AlbaServicio de Microbiología, Oviedo, Spain.
Susana Rojo-AlbaServicio de Microbiología, Oviedo, Spain.
Zulema Perez-MartinezServicio de Microbiología, Oviedo, Spain.
Jose A BogaServicio de Microbiología, Oviedo, Spain.
Marta Elena Alvarez-ArguellesServicio de Microbiología, Oviedo, Spain.
Juan GomezInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Pablo HerreroInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Isabel CostalesServicio de Microbiología, Oviedo, Spain.
Luz Maria AlbaServicio de Microbiología, Oviedo, Spain.
Gabriel Martin-RodriguezServicio de Microbiología, Oviedo, Spain.
Rainer CampoServicio de Microbiología, Oviedo, Spain.
Cristian Castelló-AbietarServicio de Microbiología, Oviedo, Spain.
Marta SandovalServicio de Microbiología, Oviedo, Spain.
Fátima Abreu-SalinasServicio de Microbiología, Oviedo, Spain.
Eliecer CotoInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Mercedes RodriguezServicio de Microbiología, Oviedo, Spain.
Pablo RubianesInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Maria Luisa SanchezServicio de Microbiología, Oviedo, Spain.
Fernando VazquezServicio de Microbiología, Oviedo, Spain.
Luis AntuñaInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Victoria ÁlvarezInstituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain.
Santiago Melón GarcíaServicio de Microbiología, Oviedo, Spain.ORCID https://orcid.org/0000-0001-5770-7902

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutational analysis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can quantify the relative importance of variants over time, enable dominant mutations to be identified, and facilitate near real-time detection, comparison and tracking of evolving variants. SARS-CoV-2 in Asturias, an autonomous community of Spain with a large ageing population, and high levels of migration and tourism, was monitored and tracked from the beginning of the pandemic in February 2020 until its decline and stabilization in August 2021, and samples were characterized using whole genomic sequencing and single nucleotide polymorphisms. Data held in the GISAID database were analysed to establish patterns in the appearance and persistence of SARS-CoV-2 strains. Only 138 non-synonymous mutations occurring in more than 1 % of the population with SARS-CoV-2 were found, identifying ten major variants worldwide (seven arose before January 2021), 19 regional and one local. In Asturias only 17 different variants were found. After vaccination, no further regional major variants were found. Only half of the defined variants circulated and no new variants were generated, indicating that infection control measures such as rapid diagnosis, isolation and vaccination were efficient.

Indexed as

mutationsSARS-CoV-2surveillancevariants

Identifiers

PMID37841093
PMCPMC10569657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.